Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.
about
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseRabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting.Nonerosive Reflux Disease (NERD) - An Update.Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.Short-term treatment of gastroesophageal reflux disease.Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapyRabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease.Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management.Review article: management of mild and severe gastro-oesophageal reflux disease.Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safetyReview of rabeprazole in the treatment of gastro-oesophageal reflux disease.Assessment of reflux symptom severity: methodological options and their attributes.Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled TrialNon-pharmacologic treatment strategies in gastroesophageal reflux disease.Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?Community-acquired pneumonia and acid-suppressive drugs: position statementReview article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.A review of rabeprazole in the treatment of acid-related diseasesCurrent advances in the diagnosis and treatment of nonerosive reflux disease.The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis.Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?NERD: an umbrella term including heterogeneous subpopulations.The pathophysiology, diagnosis and treatment of excessive belching symptoms.PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom ReseTreatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.Does Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole?
P2860
Q24236493-45C81286-FED3-4FDB-8FC8-68386A0A1D7BQ33868511-2157DBED-16E1-40E8-9FF4-A9488841495AQ33890423-F4962875-0751-4849-BD46-37055D54F451Q34169062-5DE54CAE-9147-4134-BFC6-2D200BDAE66EQ34424848-0B7BEA42-B4A7-4ED9-AC9E-D412F2323706Q34742191-B977487B-75A8-4552-A8D4-F24532C99787Q34831226-11280E9E-5BD6-4800-A40C-B2567D7B6CFAQ35010979-77C049DD-B060-4FA1-A83C-E17E5E91E5AEQ35026352-16D71889-4C17-4769-A700-5D5EBCEF4C72Q35074278-4E9F788D-233B-457D-BF01-DA29FA0D8AD6Q35145028-9CF7E109-EFD1-40E8-9464-5AD8641ECC6EQ35145033-B7E5983E-4B13-4F4A-9108-433EFCA5B5BFQ35147233-1465D8F5-6575-46EE-945A-7385CC382EC6Q35167717-26D61CA8-F7EE-473A-AD48-299FAC474CFAQ35609697-6D320D59-642A-4248-983A-83B6A2F364DDQ35745038-A3E38F77-57C6-485B-A53A-581C6B06ED88Q35793789-D93C7F20-08AD-40C6-9A8E-18C4497E922AQ35868517-0CC2381B-AFA1-4107-B41D-0C497A0789DFQ35868527-A522E842-F28A-44D7-8211-1767BC7EB216Q35923949-C6F87EBE-58CC-4252-AE3D-48B0169D60CEQ35923959-9755A926-6620-4700-93DB-B5EA619BAA51Q35963755-24306883-C92C-43DA-84E7-5E511AA644AFQ36191254-A6DE0D2C-B218-4D14-9326-7129D3DB2C01Q36398145-B4E35368-6049-4F6D-8F0C-008B252DD7CCQ36398683-B1C4E843-3F28-4511-BE99-321A96ACF766Q36661321-35192B88-ABA1-4351-898C-D39CEB109771Q37051858-F991BA55-71AF-4931-87B7-640B0A3876B0Q37223349-8D90EBC1-DCC6-4C2A-A32E-8C959BE50D15Q37279832-CF085FCE-D8AB-4861-920E-1C18BB953385Q37366593-59A69C17-F3E7-4896-85C1-54D2D9C0735BQ37709906-D95D5A19-9084-4718-ABC1-95811CD83D21Q37864149-092B0E40-A97B-4A18-9CF7-9D793DBA64F2Q38092939-76EBC373-265B-452C-B575-52816127B734Q38227011-09AF6AEE-6E85-4710-AE45-F8D17A4B9ACCQ39252347-CBFDAB2E-0599-4072-A08B-AD118B01763DQ39255875-9EFED551-61D5-4709-9A46-D49492752F64Q39260588-B5B1F89F-3772-4694-84AD-C05CE9A56A2EQ39266717-17832BE3-4DF9-4432-B284-FA3AD132A910Q39273272-D643204F-B652-4AA6-B417-A061D0494C5FQ39345800-189835E1-C632-43C7-972E-C072F268FD0A
P2860
Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@en
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@nl
type
label
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@en
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@nl
prefLabel
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@en
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@nl
P2093
P2860
P1476
Rabeprazole in nonerosive gast ...... ized placebo-controlled trial.
@en
P2093
Joseph Filippone
Leonard Jokubaitis
Philip Miner
Sheldon Sloan
William Orr
P2860
P304
P356
10.1111/J.1572-0241.2002.05769.X
P407
P577
2002-06-01T00:00:00Z